Roanoke Asset Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Roanoke Asset Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-124,549	Closed	-$386K	–	105
2016 Q1	$386K	Sell	124,549 -116,347	-48%	-$390K	0.18%	72
2015 Q4	$1.1M	Sell	240,896 -33,030	-12%	-$157K	0.47%	55
2015 Q3	$1.29M	Hold	273,926	–	–	0.47%	55
2015 Q2	$1.96M	Buy	273,926 +7,030	+3%	+$52.9K	0.63%	51
2015 Q1	$2.26M	Buy	266,896 +950	+0.4%	+$8.09K	0.74%	48
2014 Q4	$2.48M	Buy	265,946 +109,685	+70%	+$954K	0.85%	45
2014 Q3	$1.3M	Buy	156,261 +44,144	+39%	+$409K	0.53%	52
2014 Q2	$1.3M	Buy	112,117 +79,376	+242%	+$815K	0.5%	57
2014 Q1	$415K	Hold	32,741	–	–	0.18%	76
2013 Q4	$354K	Hold	32,741	–	–	0.16%	81
2013 Q3	$390K	Buy	+32,741	New	+$453K	0.19%	75

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Roanoke Asset Management's DSCI Position: Q2 2016 in Review

Roanoke Asset Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2016, closing a stake of 124,549 shares — an estimated $386K sold.

Roanoke Asset Management first reported a position in DSCI in Q3 2013 and held it in 11 quarters. The position peaked at $2.48M in Q4 2014. 53 funds tracked by Wall St. Rank hold DSCI as of Q2 2016.

Roanoke Asset Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2016 after selling out during the quarter.
Roanoke Asset Management sold 124,549 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2016, an estimated $386K.
Roanoke Asset Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q3 2013 and held it in 11 quarters.
Roanoke Asset Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $2.48M in Q4 2014.
53 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2016.

Based on Roanoke Asset Management's 13F filing for Q2 2016, filed 2 Aug 2016.